PCDQ’s opinion on biosimilar insulins

April 18, 2024

Here is an opinion from the Professional Council of Diabetes Québec (PCDQ) on the efficacy of biosimilar insulins for the treatment of diabetes.

Consult the document (in French only)

© Diabetes Québec

Further reading

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.